Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors.
News & Media
- Neuchatel, Switzerland
- Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to […]
- Irvine, California
- Masimo (NASDAQ: MASI) today announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been granted an FDA De Novo classification, is the first e […]
- Irvine, California
- Masimo (NASDAQ: MASI) announced today that Centroid™, a wearable, wireless patient orientation, activity, and respiration rate sensor, has received FDA clearance. Centroid helps clinicians monitor patient position to avoid preventable pressure ulcers […]
Discover More at Masimo
Masimo Personal Health
MightySat is for people who want to improve their health, wellness, or fitness by providing key measurements that are more accurate & not available on other health and wellness devices. […]
Patient Safety Movement
The Patient Safety Movement Foundation isn’t just hoping for ZERO preventable patient deaths in healthcare globally, they’re planning for ZERO. […]
2019 Masimo Annual Report
2019 Masimo Annual Report
Patient Safety To The Core -
Patient Safety Is in Our DNA. […]
SedLine de nouvelle génération ne dispose pas de licence de vente au Canada.
For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.